Indications for subthalamic nucleus deep brain stimulation surgery

Deep Brain Stimulation for Parkinson's Disease

Volumn , Issue , 2007, Pages 41-54

  Chou, Kelvin L ^a  

^a NeuroHealth Parkinson's Disease and Movement Disorders Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349303928     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Marras C, Tanner CM. Epidemiology of Parkinson's disease. In: Watts RL, Koller WC, eds. Movement Disorders: Neurologic Principles and Practice. 2nd ed. New York: The McGraw-Hill Companies, Inc., 2004:177-195.
2. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998; 339(15):1044-1053.
3. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely, and Jones, 1817.
4. Speigel EA, Wycis HT, Marks M, et al. Stereotaxic apparatus for operations on the human brain. Science 1947; 106:349-350.
5. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992; 76(1):53-61.
6. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345(8942): 91-95.
7. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7(1):2-13.
8. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999; 14(4):572-584.
9. Visser-Vandewalle V, Temel Y, Colle H, et al. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy-parkinsonism. Report of four cases. J Neurosurg 2003; 98(4):882-887.
10. Tarsy D, Apetauerova D, Ryan P, et al. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003; 61(2):247-249.
11. Krack P, Dowsey PL, Benabid AL, et al. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism. Neurology 2000; 54(11): 2182-2184.
12. Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005; 62(8): 1250-1255.
13. Chou KL, Forman MS, Trojanowski JQ, et al. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. J Neurosurg 2004; 100(3): 553-556.
14. Lezcano E, Gomez-Esteban JC, Zarranz JJ, et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 2004; 19(8):973-977.
15. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55(3):181-184.
16. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 1991; 18(3):275-278.
17. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57(8):1497-1499.
18. Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125(Pt 4):861-870.
19. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56(1):33-39.
20. Quinn NP. How to diagnose multiple system atrophy. Mov Disord 2005; 20 (suppl 12):S5-S10.
21. Scaravilli T, Tolosa E, Ferrer I. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov Disord 2005; 20(suppl 12):S21-S28.
22. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59(6):932-934.
23. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002; 125(Pt 3):575-583.
24. Kleiner-Fisman G, Fisman DN, Sime E, et al. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003; 99(3):489-495.
25. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349(20):1925-1934.
26. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005; 76(12):1640-1644.
27. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128(Pt 10):2240-2249.
28. Agid Y. Parkinson's disease: pathophysiology. Lancet 1991; 337(8753):1321-1324.
29. Krack P, Benazzouz A, Pollak P, et al. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord 1998; 13(6):907-914.
30. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003; 18(11):1332-1337.
31. Pahwa R, Wilkinson SB, Overman J, et al. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005; 83(2-3):80-83.
32. Jaggi JL, Umemura A, Hurtig HI, et al. Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: surgical efficacy and prediction of outcome. Stereotact Funct Neurosurg 2004; 82(2-3):104-114.
33. Pinter MM, Alesch F, Murg M, et al. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol 1999; 246(10): 907-913.
34. Deep Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345(13):956-963.
35. Friedman JH, Lannon MC. Clozapine-responsive tremor in Parkinson's disease. Mov Disord 1990; 5(3):225-229.
36. Benazzouz A, Gao DM, Ni ZG, et al. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 2000; 99(2):289-295.
37. Rodriguez MC, Obeso JA, Olanow CW. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 1998; 44(3 suppl 1): S175-S188.
38. Nakao N, Nakai E, Nakai K, et al. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann Neurol 1999; 45(5):640-651.
39. Piallat B, Benazzouz A, Benabid AL. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease. J Neural Transm Suppl 1999; 55: 71-77.
40. HiLker R, Portman AT, Voges J, et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2005; 76(9):1217-1221.
41. Morrish PK, Rakshi JS, Bailey DL, et al. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with (18F)dopa PET. J Neurol Neurosurg Psychiatry 1998; 64(3):314-319.
42. Morrish PK, Sawle GV, Brooks DJ. An (18F)dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996; 119(Pt 2):585-591.
43. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3):189-198.
44. Mattis S. Dementia Rating Scale Professonal Manual. Odessa, FL: Psychological Assessment Resources, 1988.
45. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
46. Saint-Cyr JA, Trepanier LL, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123(Pt 10):2091-2108.
47. Hariz MI, Johansson F, Shamsgovara P, et al. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov Disord 2000; 15(1):136-139.
48. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339(16):1105-1111.
49. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75(6):834-839.
50. Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002; 59(9): 1427-1429.
51. Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002; 17(5):1084-1085.
52. Krack P, Limousin P, Benabid AL, et al. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet 1997; 350(9092):1676.
53. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999; 340(19):1476-1480.
54. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72(6):701-707.
55. Chou KL, Hurtig HI, Jaggi JL, et al. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism Relat Disord 2005; 11(6):403-406.
56. Blin J, Dubois B, Bonnet AM, et al. Does ageing aggravate parkinsonian disability? J Neurol Neurosurg Psychiatry 1991; 54(9):780-782.
57. Russmann H, Ghika J, Villemure JG, et al. Subthalamic nucleus deep brain stimulation in Parkinson's disease patients over age 70 years. Neurology 2004; 63(10): 1952-1954.
58. Lopiano L, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes. J Neurol Sci 2002; 195(2):167-170.
59. Okun MS, Fernandez HH, Pedraza O, et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology 2004; 63(1): 161-163.